Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells - PubMed (original) (raw)

Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells

Zhiwei Wang et al. Cancer Res. 2006.

Retraction in

Abstract

Notch signaling plays a critical role in the pathogenesis and progression of human malignancies but the precise role and mechanism of Notch-1 for tumor invasion remains unclear. In our earlier report, we showed that down-regulation of Notch-1 reduced nuclear factor-kappaB (NF-kappaB) DNA-binding activity and matrix metalloproteinase-9 (MMP-9) expression. Because NF-kappaB, VEGF, and MMPs are critically involved in the processes of tumor cell invasion and metastasis, we investigated the role and mechanism(s) by which Notch-1 down-regulation (using molecular approaches) may lead to the down-regulation of NF-kappaB, vascular endothelial growth factor (VEGF), and MMP-9, thereby inhibiting invasion of pancreatic cancer cells through Matrigel. We found that the down-regulation of Notch-1 by small interfering RNA decreased cell invasion, whereas Notch-1 overexpression by cDNA transfection led to increased tumor cell invasion. Consistent with these results, we found that the down-regulation of Notch-1 reduced NF-kappaB DNA-binding activity and VEGF expression. Down-regulation of Notch-1 also decreased not only MMP-9 mRNA and its protein expression but also inactivated the pro-MMP-9 protein to its active form. Taken together, we conclude that the down-regulation of Notch-1 could be an effective approach for the down-regulation and inactivation of NF-kappaB and its target genes, such as MMP-9 and VEGF expression, resulting in the inhibition of invasion and metastasis.

PubMed Disclaimer

Cited by

Evaluation of in vitro and in vivo anticancer activities of potassium koetjapate: a solubility improved formulation of koetjapic acid against human colon cancer.
Jafari SF, Keshavarzi M, AbdulMajid AM, Al-Suede FSR, Asif M, Ahamed MBK, Khan MSS, Hassan LAE, Majid ASA, Naseri M. Jafari SF, et al. Res Pharm Sci. 2024 Apr 1;19(2):203-216. doi: 10.4103/RPS.RPS_247_22. eCollection 2024 Apr. Res Pharm Sci. 2024. PMID: 39035582 Free PMC article.
Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer.
Chen H, Yu Y, Zhou L, Chen J, Li Z, Tan X. Chen H, et al. Front Genet. 2023 Jan 13;14:1049454. doi: 10.3389/fgene.2023.1049454. eCollection 2023. Front Genet. 2023. PMID: 36713077 Free PMC article.
Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment.
Kilmister EJ, Koh SP, Weth FR, Gray C, Tan ST. Kilmister EJ, et al. Biomedicines. 2022 Nov 21;10(11):2988. doi: 10.3390/biomedicines10112988. Biomedicines. 2022. PMID: 36428556 Free PMC article. Review.
Reposition of the anti-inflammatory drug diacerein in an in-vivo colorectal cancer model.
Abdel-Latif RT, Wadie W, Abdel-Mottaleb Y, Abdallah DM, El-Maraghy NN, El-Abhar HS. Abdel-Latif RT, et al. Saudi Pharm J. 2022 Jan;30(1):72-90. doi: 10.1016/j.jsps.2021.12.009. Epub 2021 Dec 31. Saudi Pharm J. 2022. PMID: 35145347 Free PMC article.
Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview.
Hamidi AA, Khalili-Tanha G, Nasrpour Navaei Z, Moghbeli M. Hamidi AA, et al. Cancer Cell Int. 2022 Feb 10;22(1):71. doi: 10.1186/s12935-022-02501-5. Cancer Cell Int. 2022. PMID: 35144601 Free PMC article. Review.

Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells - PubMed (original) (raw)